Stockreport

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF New and updated data from EPCORE ® clinical trial program reinforce the potential of epcoritamab as a monotherapy and in combination to treat multiple B-cell malignanci [Read more]